Heart Metabolics Limited
5 articles about Heart Metabolics Limited
-
Heart Metabolics Limited Announces Initiation Of Phase 2b Study Of Perhexiline For Hypertrophic Cardiomyopathy
8/31/2016
-
Heart Metabolics Limited Adds New Board Member And Expands Senior Management Team
5/17/2016
-
Heart Metabolics Limited Announces Multiple Senior Appointments To Management Team
3/15/2016
-
Heart Metabolics Limited And FDA Reach Agreement On Special Protocol Assessment For Single Phase 3 Trial Of Perhexiline In Hypertrophic Cardiomyopathy
4/15/2015
-
Startup Heart Metabolics Limited Launches With $20 Million In Pocket
4/17/2014